Table 4.
IMT in the glycemic index, autonomic function, and functional capacity.
| Study | PEDro score | Diaphragmatic muscle strength | Glycemic index | Autonomic function | Functional capacity |
|---|---|---|---|---|---|
| Ahmad, 2020 | 4 | Not mentioned | There was no statistical difference | Not assessed | Not assessed |
| Albarrati, 2020 | 7 | Increased MIP | Not assessed | Not assessed | Increase in 6WT covered distance, TUG time, and palm grip strength |
| Correa, 2011 | 6 | Increased MIP | Not assessed | There was no statistical difference | There were no significant results |
| Kaminski, 2015 | 4 | Increased MIP | Not assessed | Reduction of the sympathetic component (LFn) |
There were no significant results |
| Mowad, 2020 | 5 | Increased MIP | Not assessed | Not assessed | Increased VO₂max |
| Pinto, 2021 | 9 | Increased endurance | Reduced glycemic levels after 8 weeks of IMT at 30%
MIP, with no difference after 12 weeks, neither in HbA1c |
Not assessed | Not assessed |
6WT=six-minute walk test; HbA1c=glycated hemoglobin; IMT=inspiratory muscle training; LFn=normalized low frequency; MIP=maximum inspiratory pressure; PEDro=Physiotherapy Evidence Database; TUG=Timed Up and Go; VO₂max=maximal oxygen consumption